NCT02672904

Brief Summary

comparison results of treatment of early stage glottic cancer between two methods of surgical treatment - CO2 laser and KTP laser

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

January 26, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 3, 2016

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2020

Completed
Last Updated

October 11, 2016

Status Verified

August 1, 2016

Enrollment Period

6 years

First QC Date

January 26, 2016

Last Update Submit

October 10, 2016

Conditions

Keywords

vocal cordcarcinomaktp laserco2 laserendoscopic surgery

Outcome Measures

Primary Outcomes (7)

  • Duration of surgery

    total time (minutes) of surgical procedure

    intraoperative

  • number of surgical interventions

    total number of surgical interventions needed to eliminate the disease

    3 years

  • Recovery time after surgery

    recovery in terms of overall function, breathing, swallowing and vocal communication

    up to 3 years

  • voice quality results In the short term

    objective measurement- voice lab analysis, and subjective measurement- Voice Handicap Index questionnaire

    6 month after last intervention

  • voice quality results In the long term

    objective measurement- voice lab analysis, and subjective measurement- Voice Handicap Index questionnaire

    3 years after last intervention

  • Cure rates in terms of local, regional or distant recurrence events

    evidence of malignant disease in the larynx, cervical lymph nodes or distant metastases

    3 years after last intervention

  • Overall survival and disease-dependent survival over a period of at least 3 years

    3 years after last intervention

Study Arms (2)

CO2 laser

ACTIVE COMPARATOR

Patients undergoing endoscopic treatment with CO2 laser

Device: CO2 laser

KTP laser

ACTIVE COMPARATOR

Patients undergoing endoscopic treatment with KTP laser

Device: KTP laser

Interventions

CO2 laserDEVICE

surgical removal of carcinoma from the vocal cords with CO2 laser

CO2 laser
KTP laserDEVICE

surgical removal of carcinoma from the vocal cords with KTP laser

KTP laser

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with pre-operative diagnosis of squamous cell cancer of the vocal cords at an early stage ( Carcinoma in situ or T1-glottic carcinoma).

You may not qualify if:

  • Patients who underwent previous significant vocal cords surgical intervention , or irradiation.
  • Contraindications to any endoscopic surgical treatment (general health condition, patient refusal, technical surgical difficulties)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kapkan medical center

Rehovot, Israel

RECRUITING

Related Publications (8)

  • Burns JA, Friedman AD, Lutch MJ, Hillman RE, Zeitels SM. Value and utility of 532 nanometre pulsed potassium-titanyl-phosphate laser in endoscopic laryngeal surgery. J Laryngol Otol. 2010 Apr;124(4):407-11. doi: 10.1017/S0022215109991824. Epub 2009 Nov 27.

    PMID: 19941682BACKGROUND
  • Zeitels SM, Burns JA, Lopez-Guerra G, Anderson RR, Hillman RE. Photoangiolytic laser treatment of early glottic cancer: a new management strategy. Ann Otol Rhinol Laryngol Suppl. 2008 Jul;199:3-24. doi: 10.1177/00034894081170s701.

    PMID: 18710131BACKGROUND
  • Lin DS, Cheng SC, Su WF. Potassium titanyl phosphate laser treatment of intubation vocal granuloma. Eur Arch Otorhinolaryngol. 2008 Oct;265(10):1233-8. doi: 10.1007/s00405-008-0628-6. Epub 2008 Mar 4.

    PMID: 18317789BACKGROUND
  • Zeitels SM, Akst LM, Bums JA, Hillman RE, Broadhurst MS, Anderson RR. Pulsed angiolytic laser treatment of ectasias and varices in singers. Ann Otol Rhinol Laryngol. 2006 Aug;115(8):571-80. doi: 10.1177/000348940611500802.

    PMID: 16944655BACKGROUND
  • Hirano S, Yamashita M, Kitamura M, Takagita S. Photocoagulation of microvascular and hemorrhagic lesions of the vocal fold with the KTP laser. Ann Otol Rhinol Laryngol. 2006 Apr;115(4):253-9. doi: 10.1177/000348940611500402.

    PMID: 16676821BACKGROUND
  • Kacker A, April M, Ward RF. Use of potassium titanyl phosphate (KTP) laser in management of subglottic hemangiomas. Int J Pediatr Otorhinolaryngol. 2001 May 31;59(1):15-21. doi: 10.1016/s0165-5876(01)00451-7.

    PMID: 11376814BACKGROUND
  • Zeitels SM, Burns JA. Office-based laryngeal laser surgery with the 532-nm pulsed-potassium-titanyl-phosphate laser. Curr Opin Otolaryngol Head Neck Surg. 2007 Dec;15(6):394-400. doi: 10.1097/MOO.0b013e3282f1fbb2.

    PMID: 17986877BACKGROUND
  • Zeitels SM, Akst LM, Burns JA, Hillman RE, Broadhurst MS, Anderson RR. Office-based 532-nm pulsed KTP laser treatment of glottal papillomatosis and dysplasia. Ann Otol Rhinol Laryngol. 2006 Sep;115(9):679-85. doi: 10.1177/000348940611500905.

    PMID: 17044539BACKGROUND

MeSH Terms

Conditions

Laryngeal NeoplasmsCarcinoma

Interventions

Lasers, GasLasers, Solid-State

Condition Hierarchy (Ancestors)

Otorhinolaryngologic NeoplasmsHead and Neck NeoplasmsNeoplasms by SiteNeoplasmsLaryngeal DiseasesRespiratory Tract DiseasesRespiratory Tract NeoplasmsOtorhinolaryngologic DiseasesNeoplasms, Glandular and EpithelialNeoplasms by Histologic Type

Intervention Hierarchy (Ancestors)

LasersOptical DevicesEquipment and SuppliesRadiation Equipment and Supplies

Study Officials

  • Yonatan Lahav, Dr

    Kaplan Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr Yonatan Lahav

Study Record Dates

First Submitted

January 26, 2016

First Posted

February 3, 2016

Study Start

January 1, 2013

Primary Completion

January 1, 2019

Study Completion

January 1, 2020

Last Updated

October 11, 2016

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will not share

Locations